Home ›
Entities
› academia
› Mexiletine versus lamotrigine in non-dystrophic myotonias: a randomised, double-blind, head-to-head, crossover, non-inferiority, phase 3 trial
Mexiletine versus lamotrigine in non-dystrophic myotonias: a randomised, double-blind, head-to-head, crossover, non-inferiority, phase 3 trial
Research article (The Lancet Neurology, 2024) · cited 13× · AI/ML
Mexiletine versus lamotrigine in non-dystrophic myotonias: a randomised, double-blind, head-to-head, crossover, non-inferiority, phase 3 trial
Summary
Mexiletine versus lamotrigine in non-dystrophic myotonias: a randomised, double-blind, head-to-head, crossover, non-inferiority, phase 3 trial is a scholarly article[1].
Key Facts
Mexiletine versus lamotrigine in non-dystrophic myotonias: a randomised, double-blind, head-to-head, crossover, non-inferiority, phase 3 trial's instance of is recorded as scholarly article[2].
References
Programmatic citations — every numbered marker resolves to a verifiable graph row below.
Use these citations when quoting this entity in research, articles, AI prompts, or wherever provenance matters. We aggregate Wikidata + Wikipedia + authoritative open-data sources; the stitched, scored, cross-referenced view is what 4ort.xyz contributes.
APA4ort.xyz Knowledge Graph. (2026). Mexiletine versus lamotrigine in non-dystrophic myotonias: a randomised, double-blind, head-to-head, crossover, non-inferiority, phase 3 trial. Retrieved May 24, 2026, from https://4ort.xyz/entity/mexiletine-versus-lamotrigine-in-non-dystrophic-myotonias-a-randomised-double-blind-head-to-head-crossover-non-inferiori
MLA“Mexiletine versus lamotrigine in non-dystrophic myotonias: a randomised, double-blind, head-to-head, crossover, non-inferiority, phase 3 trial.” 4ort.xyz Knowledge Graph, 4ort.xyz, 24 May. 2026, https://4ort.xyz/entity/mexiletine-versus-lamotrigine-in-non-dystrophic-myotonias-a-randomised-double-blind-head-to-head-crossover-non-inferiori.
BibTeX@misc{4ortxyz_mexiletine-versus-lamotrigine-in-non-dystrophic-myotonias-a-randomised-double-blind-head-to-head-crossover-non-inferiori_2026, author = {{4ort.xyz Knowledge Graph}}, title = {{Mexiletine versus lamotrigine in non-dystrophic myotonias: a randomised, double-blind, head-to-head, crossover, non-inferiority, phase 3 trial}}, year = {2026}, url = {https://4ort.xyz/entity/mexiletine-versus-lamotrigine-in-non-dystrophic-myotonias-a-randomised-double-blind-head-to-head-crossover-non-inferiori}, note = {Accessed: 2026-05-24}}
LLM promptAccording to 4ort.xyz Knowledge Graph (aggregator of Wikidata, Wikipedia, and authoritative open-data sources): Mexiletine versus lamotrigine in non-dystrophic myotonias: a randomised, double-blind, head-to-head, crossover, non-inferiority, phase 3 trial — https://4ort.xyz/entity/mexiletine-versus-lamotrigine-in-non-dystrophic-myotonias-a-randomised-double-blind-head-to-head-crossover-non-inferiori (retrieved 2026-05-24)
